Browse our catalogue of products
10 products displayed
Ref-SKU | Type | Product | Virus name | Product Risk Group | Provider | Cost per Access (Academics) | Add to Cart |
---|---|---|---|---|---|---|---|
017V-05412 | Virus | SARS-CoV-2 isolate - hCoV-19/France/IDF-IPP17625/2023, lineage JN.5 | SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | RG3 | IP | 2,000€ | Free access available |
017V-06135 | Virus |
Human Respiratory syncytial virus A, hRSV/A/FR/GES-IPP30442/2023, epidemic isolate
Reference Strain |
Human respiratory syncytial virus A | RG2 | IP | 1,000€ | Free access available |
017V-05460 | Virus |
SARS-CoV-2 isolate - hCoV-19/France/NOR-IPP20774/2023, lineage JN.1.1
Reference Strain |
SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | RG3 | IP | 2,000€ | Free access available |
017V-05465 | Virus |
Human Influenza A(H3N2) virus, A/Franche_Comte/01892/2023, epidemic isolate clade 3C.2a1b.2a.2
Reference Strain |
Influenza A virus | RG2 | IP | 500€ | Free access available |
017V-05464 | Virus |
Human Influenza A(H1N1)pdm09 virus, A/Bretagne/06091/2023, epidemic isolate clade 6B.1A.5a.2
Reference Strain |
Influenza A virus | RG2 | IP | 500€ | Free access available |
017V-05461 | Virus |
SARS-CoV-2 isolate - hCoV-19/France/NOR-IPP21033/2023, lineage DV.7.1
Reference Strain |
SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | RG3 | IP | 2,000€ | Free access available |
017V-05411 | Virus |
Human SARS-CoV-2 hCoV-19/France/IDF-IPP16753/2023, lineage FL.1.5.1
Reference Strain |
SARS-CoV-2 | RG3 | IP | 2,000€ | Free access available |
017V-05363 | Virus |
SARS-CoV-2 isolate - hCoV-19/France/GES-IPP15954/2023, lineage EG.5.1.1
Reference Strain |
SARS-CoV-2 | RG3 | IP | 2,000€ | Free access available |
017V-05364 | Virus |
SARS-CoV-2 isolate - hCoV-19/France/BRE-IPP15906/2023, lineage EG.5.1.3
Reference Strain |
SARS-CoV-2 | RG3 | IP | 2,000€ | Free access available |
017V-05211 | Virus |
Human SARS-CoV-2, hCoV-19/France/GES-IPP07712/2023, Omicron, lineage XBB.1.16.1
Reference Strain |
SARS-CoV-2 | RG3 | IP | 2,000€ | Free access available |